4.3 Article

Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes

Journal

ONCOTARGET
Volume 8, Issue 41, Pages 70481-70495

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.19719

Keywords

triple-negative breast cancer; molecular subtype; functional; proteomics; mRNA microarray

Funding

  1. Morgan Welch Inflammatory Breast Cancer Research Program
  2. State of Texas Rare and Aggressive Breast Cancer Research Program Grant
  3. NIH/NCI [P30CA016672]

Ask authors/readers for more resources

Background: Reverse phase protein array (RPPA) analysis, allows investigation of potential targets at the functional protein level,. We identified TNBC subtypes at the protein level using RPPA and compared them with mRNA molecular subtypes (TNBCtype, TNBCtype-4, and PAM50) that is unique in its availability of both RPPA and mRNA analyses. Methods: We classified the samples from 80 TNBC patients using both k-means and hierarchical consensus clustering analysis and performed Ingenuity Pathway Analysis. We also investigated whether we could reproduce the mRNA molecular subtypes using the RPPA dataset. Results: Both clustering methods divided all samples into 2 clusters that were biologically the same. The top canonical pathways included inflammation, hormonal receptors, and MAPK signaling pathways for the first cluster [inflammation and hormonal-related (I/H) subtype] and the GADD45, DNA damage, and p53 signaling pathways for the second cluster [DNA damage (DD)-related subtype]. Further k-means cluster analysis identified 5 TNBC clusters. Comparison between sample classification using the 5 RPPA-based k-means cluster subtypes and 6 gene-expression- based TNBCtype molecular subtypes showed significant association between the 2 classifications (p = 0.017). Conclusions: The I/H and DD subtypes identified by RPPA advance our understanding of TNBC's heterogeneity from the functional proteomic perspective.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available